Insomnia Clinical Trial
— GASOfficial title:
Pregnancy With Insomnia: a Trial of Acupuncture
Acupuncture is widely used for treatment of insomnia. The research hypothesis is that
acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.
GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity
index (ISI) as the main outcome criterion.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | May 2019 |
Est. primary completion date | January 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age > 18 years - Singleton pregnancy - Gestational age = 16 weeks + 0 day and = 32 weeks + 6 days - Insomnia Severity Index = 10 - Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion - Patient understanding the study - Informed consent signed - Social insurance available at inclusion and until the end of pregnancy Exclusion Criteria: - Threatened premature labor - Small fetus for gestational age - Pre-eclampsia - Insomnia starting before pregnancy - Use of psychotropic drugs before pregnancy - Use of recreational drugs during pregnancy - Known psychiatric disorder - Anticoagulant therapy - Patient reporting insomnia results from chronic or acute pain - Obstructive sleep apnea (OSA) requiring treatment - Patient under antidepressant therapy - Patient under legal guardianship or deprived of freedom |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Insomnia severity index (ISI) | Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Pittsburgh Sleep Quality Index (PSQI) | Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Hospital Anxiety and Depression Scale (HADS) | Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Cumulated dose of each psychotropic medicine | During the study period, the patients will note on a logbook the daily use of any drug. | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Cumulated dose of alcohol | During the study period, the patients will note on a logbook the daily use of alcohol. | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Cumulated dose of tobacco | During the study period, the patients will note on a logbook the daily use of tobacco. | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Cumulated dose of cannabis | During the study period, the patients will note on a logbook the daily use of cannabis. | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Cumulated dose of other recreational substances or medicine | During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine. | Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Difference in the frequency of restless leg syndrome | According to the guidelines of the International Restless Legs Syndrome Study Group. The diagnosis of restless leg will rely on the presence of all of the following criteria: Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities. Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs. Symptoms are worse at rest with at least temporary relief by activity. Symptoms are worse later in the day or at night. |
Inclusion visit and 5 weeks after the first acupuncture session | |
Secondary | Perinatal outcome - Gestational age at birth | The gestational age at birth of the newborn will be recorded. | At birth | |
Secondary | Perinatal outcome - birth weight | The weight (in gr) at birth of the newborn will be recorded. | At birth | |
Secondary | Perinatal outcome - birth height | The height (in cm) at birth of the newborn will be recorded. | At birth | |
Secondary | Perinatal outcome - sex | The sex of the newborn will be recorded. | At birth | |
Secondary | Perinatal outcome - perinatal mortality | The perinatal mortality will be recorded. | At birth | |
Secondary | Perinatal outcome - five minutes Apgar score | The five minutes Apgar score will be recorded. | At birth | |
Secondary | Perinatal outcome - cesarean section rate | Cesarean section rate will be recorded. | At birth. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Completed |
NCT06339853 -
Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia
|
N/A | |
Recruiting |
NCT04069247 -
Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia
|
N/A | |
Completed |
NCT04493593 -
Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Recruiting |
NCT06278077 -
Neurexan - a Clinical Trial in Short-Term Insomnia Patients
|
Phase 2 | |
Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
Recruiting |
NCT06207279 -
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
|
||
Recruiting |
NCT06006299 -
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04035200 -
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
|
Phase 2 | |
Active, not recruiting |
NCT05027438 -
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
|
N/A | |
Recruiting |
NCT06053840 -
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia
|
Phase 4 | |
Not yet recruiting |
NCT06348082 -
Project Women's Insomnia Sleep Health Equity Study (WISHES)
|
N/A | |
Not yet recruiting |
NCT06363799 -
Osteopathic Protocol for Insomnia in College Students
|
N/A | |
Not yet recruiting |
NCT05991492 -
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
|
N/A | |
Not yet recruiting |
NCT06025968 -
Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis
|
N/A |